World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Feb 02
Some painkillers push low testosterone risk five-fold: Study
People taking long-acting pain killers for extended periods face a five-times greater risk of low testosterone, the male sex hormone, a new study says.

The study is the first to compare the use of short-acting opioids, which immediately release the drug, taken every four to six hours, and long-acting opioids, which slowly release the medication and are taken every eight to 12 hours.
The 81 men involved in the study were between 26 and 79 years old (median age 51) and were seen in the chronic-pain clinic at Kaiser Permanente`s Santa Rosa Medical Centre, California (KPSRMC), between January 2009 and June 2010, the Clinical Journal of Pain reports.

All of the participants had been on a stable dose of an opioid for at least three months, and none had a previous diagnosis of low testosterone. A larger retrospective study of more than 1,500 male pain patients is currently under way, according to a KPSRMC statement.

"There`s a large gap in the evidence base with regard to opioids," said Andrea Rubinstein from the departments of chronic pain and anesthesiology, KPSRMC.

"More safety and efficacy studies are needed. We need to know how we can prescribe these very useful medications in a way that brings the greatest benefits to our patients, without introducing additional risks."

Once prescribed primarily to cancer patients, the use of opioid-based medications such as oxycodone (Oxycontin) and hydrocodone (Vicodin) for treating chronic, non-cancer pain has increased dramatically in recent decades. An estimated 4.3 million Americans use opioids on a daily basis for pain.

"For years, doctors have been encouraged to prescribe long-acting opioids rather than short-acting opioids because we believed they were safer, had less abuse potential, and offered more consistent pain control, but no study has ever been able to support this practice," Rubinstein said.

A healthy young man should have testosterone levels between 300 and 800 nanograms per decilitre (ng/dL). Low testosterone, also known as hypogonadism, was defined as less than 250 ng/dL.

A decilitre is one-tenth of a litre.

Low testosterone levels have been linked with decreases in muscle mass, bone density (osteoporosis or osteopenia), cognition, mood, libido (sex drive) and general quality of life.

Seventy-four percent of the men on long-acting opioids had low testosterone levels, compared with 34 percent of the men using short-acting opioids.

After controlling for daily dosage and body mass index, the study found that the odds of having low testosterone were 4.78 times greater for men taking a long-acting opioid than a short-acting opioid.

Feb 02
Excessive alcohol use can damage youngsters brain
A new study has highlighted the significant changes in brain function and structure that can be caused by excessive alcohol use in young people.

Functional signs of brain damage from alcohol misuse in young people mainly include deficits in visual learning and memory as well as executive functions, according to the study published in Cortex.


These functions are controlled by the hippocampus and frontal structures of the brain, which are not fully mature until around 25 years of age. Structural signs of alcohol misuse in young people include shrinking of the brain and significant changes to white matter tracts.

Age of first use may be considered to trigger alcohol misuse. According to the researchers however, changing the legal drinking age is not the answer.

In Australia the legal drinking age is 18, three years earlier than in the US. Despite the difference in legal drinking age, the age of first use (and associated problems) is the same between the two countries.

Instead, the authors stressed the need for early intervention, by identifying markers and thresholds of risky drinking behaviour at an early stage, while individuals are in vulnerable stages of brain development.

Feb 01
Binge drinking raises Type 2 diabetes risk
Binge drinking interferes with the area of the brain that controls insulin regulation, which increases your risk of developing Type 2 diabetes, a new study has warned.

"Insulin resistance has emerged as a key metabolic defect leading to Type 2 diabetes and coronary artery disease (CAD)," said Christoph Buettner, MD, PhD, senior author of the study and Associate Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at Mount Sinai.

"Someone who regularly binge drinks even once a week, over many years, may remain in an insulin resistant state for an extended period of time, potentially years," said Dr. Buettner.

Researchers in this study were able to show that it is alcohol`s effect on the brain - specifically the hypothalamus, the area that controls metabolism - that makes the body less able to process insulin.

The study was conducted on a group of rats, some of which were given alcohol over a three-day period to mimic binge drinking, while others received the same amount of sugar calories from other food sources. The rats who drank alcohol were then found to have higher concentrations of plasma insulin, an indicator of metabolic syndrome, which increases one`s risk for diabetes.

Researchers also identified inflammation occurring in the drinking rats` brains. When they inhibited the protein that causes inflammation in the hypothalamus, they were able to prevent insulin resistance.

Binge drinking is commonly defined as 4 drinks in a 2-hour span for women, or 5 for men.

The study was recently published in the journal Science Translational Medicine.

Feb 01
Vegetarian diet slashes risk of heart disease, researchers find
Vegetarians are much less likely to suffer from serious heart disease than their carnivorous counterparts, British researchers have found.

A University of Oxford study analyzed 45,000 volunteers from England and Scotland, recruited in the 1990s and tracked until 2009.

"The results clearly show that the risk of heart disease in vegetarians is about a third lower than in comparable non-vegetarians," co-author of the study and university professor Tim Key said in a statement.

After years of analysis, researchers concluded the risk of hospitalization or death from heart disease is 32 percent lower in vegetarians than people who eat meat and fish.

"Most of the difference in risk is probably caused by effects on cholesterol and blood pressure, and shows the important role of diet in the prevention of heart disease," lead author Francesca Crowe said.

The study took into account factors such as age, smoking, alcohol intake, physical activity, educational level and socioeconomic background, and recorded the blood pressure and cholesterol levels of participants.

Overwhelmingly, researchers found that vegetarians had lower blood pressure, cholesterol levels, and body mass indices than non-vegetarians.

Browse Archive